At 4.6% CAGR, South & Central America Balloon Aortic Valvuloplasty Market is Projected to be Worth US$ 17.24 Million by 2031, says Business Market Insights

According to Business Market Insights' research, the South & Central America balloon aortic valvuloplasty market was valued at US$ 12.02 million in 2023 and is expected to reach US$ 17.24 million by 2031, registering a CAGR of 4.6% from 2023 to 2031. Advancements in aortic valve replacement technologies and rising prevalence of aortic valve stenosis are among the critical factors attributed to drive the South & Central America balloon aortic valvuloplasty market growth.

Patients with heart conditions experience improved symptoms within a shorter period when treated with transcatheter procedures compared with surgical intervention. Minimally invasive surgical techniques, such as TAVI, have modernized the treatment of aortic stenosis due to advancements. TAVI is less invasive than traditional open-heart surgery, making it possible for high-risk patients who may not have been eligible for surgery to receive treatment. Additionally, developments in design have led to the development of stronger and biocompatible aortic valve replacements, which have improved patient outcomes and lowered the risk of complications. For instance, in January 2023, Abbott received FDA approval for the Navitor TAVI system to treat patients with severe aortic stenosis and those who are ineligible for open-heart surgery. Navitor has been newly introduced in the company's extensive transcatheter structural heart portfolio; it offers physicians and patients less invasive treatment alternatives for a range of serious heart conditions. Therefore, technological advancements are offering lucrative opportunities for the balloon aortic valvuloplasty market growth.

On the contrary, the high cost of procedures hampers the growth of South & Central America balloon aortic valvuloplasty market.

Based on product type, the South & Central America balloon aortic valvuloplasty market is segmented into non compliant balloons and semi compliant balloons. The non compliant balloons segment held 71.6% market share in 2023, amassing US$ 8.60 million. It is projected to garner US$ 12.69 million by 2031 to register 5.0% CAGR during 2023-2031.

By country, the South & Central America balloon aortic valvuloplasty market is segmented into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 61.7% share of South & Central America balloon aortic valvuloplasty market in 2023. It was assessed at US$ 7.42 million in 2023 and is likely to hit US$ 10.90 million by 2031, registering a CAGR of 4.9% during 2023-2031.

Key players operating in the South & Central America balloon aortic valvuloplasty market B Braun SE; TT Medical, Inc.; Balton; Becton Dickinson and Co; Edwards Lifesciences Corp; Balt; and Venus MedTech HangZhou Inc, among others.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com